COVID-19 vaccine: Novavax delays Phase 3 testing in U.S.
Oct. 27 (UPI) -- Maryland-based biotech firm Novavax on Tuesday announced it's delayed the start of its Phase 3 testing of a potential COVID-19 in North America.
More from Maryland Non-Local Sources
NY Times on Maryland
Trump to Announce Investment in Maryland Submarine Facility
Maryland Non-Local Sources
•
Oct 6, 2026
NY Times on Maryland
Where High Rents Drive People Into Poverty
Maryland Non-Local Sources
•
Sep 29, 2026
NY Times on Maryland
At Summit, Xi Sought to Tilt Trump's Stance on America's Place in Asia
Maryland Non-Local Sources
•
Sep 26, 2026
NY Times on Maryland
American Yom Kippur: How Jews Across the U.S. Observe the Holiest Day of the Year
Maryland Non-Local Sources
•
Sep 20, 2026
NY Times on Maryland
Man Charged in Maryland Boy's Disappearance After 33 Years
Maryland Non-Local Sources
•
Sep 19, 2026
NY Times on Maryland
After a Difficult Loss, Nigeria Has Become a Source of Pain for Chimamanda Ngozi Adichie
Maryland Non-Local Sources
•
Sep 10, 2026
NY Times on Maryland
Trump Is Delayed After Emergency Slide Deploys on New Air Force One
Maryland Non-Local Sources
•
Sep 9, 2026
NY Times on Maryland
Keep Lighting the Torches That Gloria Steinem Lit
Maryland Non-Local Sources
•
Sep 8, 2026